Skip to main content
. 2023 Dec 11;15(24):5797. doi: 10.3390/cancers15245797

Figure 3.

Figure 3

Utilization of glutamine in tumours. ASL—argininosuccinate lyase (E.C. 4.3.2.1); ASS1—argininosuccinate synthase (E.C. 6.3.4.5), CAD—trifunctional protein, CPS 2—carbamoyl-phosphate synthase 2 (E.C. 6.3.5.5), ATC—aspartate transcarbamylase (E.C. 2.1.3.2) DHO—dihydroorotase (E.C. 3.5.2.3).